Investigation of the expression level of methylated septin 9 gene and serological carcinoembryonic antigen to diagnose colorectal cancer. A meta-analysis study

Sharifeh Jorboniyan, Haniyeh Bashi Zadeh Fakhar, Mohammad-Esmaiel Akbari, Neda Izadi, Shaghayegh Rangraz · 2024

Read Investigation of the expression level of methylated septin 9 gene and serological carcinoembryonic antigen to diagnose colorectal cancer. A meta-analysis study by Sharifeh Jorboniyan, Haniyeh Bashi Zadeh Fakhar, Mohammad-Esmaiel Akbari, Neda Izadi, Shaghayegh Rangraz (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11726225.txt.

Description

Sharifeh Jorboniyan and four co-authors run a meta-analysis, in 2024, of two blood markers for colorectal cancer diagnosis. One marker is methylated septin 9, and the other is carcinoembryonic antigen, a long-used test. Studies in English from January 2012 to December 2022 were gathered from PubMed and Google Scholar.

Methylated septin 9 showed 71 percent sensitivity and 91 percent specificity, well above the antigen test on both counts. An eight-study analysis also linked higher levels of both markers to higher tumour grade, most clearly at stages 3 and 4. The authors urge adding septin 9 to diagnostic frameworks to improve early detection and care.

Catalog record

CREATORSharifeh Jorboniyan, Haniyeh Bashi Zadeh Fakhar, Mohammad-Esmaiel Akbari, Neda Izadi, Shaghayegh Rangraz
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE24 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11726225

Browse the full library · About the Tower of Babel